TP53 and endometrial cancer: Currently, according to the European Society of Gynecological Oncology (ESGO) guidelines, four main types are included: POLE-ultramutated endometrial cancer (EC), MMR-deficient/microsatellite instability (MSI) EC, P53-mutated EC and non-specific molecular profile (NSMP) EC.